These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33029705)

  • 1. Folinic Acid as Adjunctive Therapy in Treatment of Inappropriate Speech in Children with Autism: A Double-Blind and Placebo-Controlled Randomized Trial.
    Batebi N; Moghaddam HS; Hasanzadeh A; Fakour Y; Mohammadi MR; Akhondzadeh S
    Child Psychiatry Hum Dev; 2021 Oct; 52(5):928-938. PubMed ID: 33029705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. l-Carnosine As an Adjunctive Therapy to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Hajizadeh-Zaker R; Ghajar A; Mesgarpour B; Afarideh M; Mohammadi MR; Akhondzadeh S
    J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):74-81. PubMed ID: 29027815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol as adjunctive therapy in treatment of irritability in children with autism: A double-blind and placebo-controlled randomized trial.
    Hendouei F; Sanjari Moghaddam H; Mohammadi MR; Taslimi N; Rezaei F; Akhondzadeh S
    J Clin Pharm Ther; 2020 Apr; 45(2):324-334. PubMed ID: 31714621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.
    Asadabadi M; Mohammadi MR; Ghanizadeh A; Modabbernia A; Ashrafi M; Hassanzadeh E; Forghani S; Akhondzadeh S
    Psychopharmacology (Berl); 2013 Jan; 225(1):51-9. PubMed ID: 22782459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risperidone Combination Therapy With Propentofylline for Treatment of Irritability in Autism Spectrum Disorders: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Behmanesh H; Moghaddam HS; Mohammadi MR; Akhondzadeh S
    Clin Neuropharmacol; 2019; 42(6):189-196. PubMed ID: 31725473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial.
    Ghaleiha A; Mohammadi E; Mohammadi MR; Farokhnia M; Modabbernia A; Yekehtaz H; Ashrafi M; Hassanzadeh E; Akhondzadeh S
    Paediatr Drugs; 2013 Dec; 15(6):505-14. PubMed ID: 23821414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Pregnenolone Adjunct to Risperidone Ameliorate Irritable Behavior in Adolescents With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial?
    Ayatollahi A; Bagheri S; Ashraf-Ganjouei A; Moradi K; Mohammadi MR; Akhondzadeh S
    Clin Neuropharmacol; 2020; 43(5):139-145. PubMed ID: 32947424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulforaphane as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled clinical trial.
    Momtazmanesh S; Amirimoghaddam-Yazdi Z; Moghaddam HS; Mohammadi MR; Akhondzadeh S
    Psychiatry Clin Neurosci; 2020 Jul; 74(7):398-405. PubMed ID: 32347624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minocycline as Adjunctive Treatment to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind Placebo-Controlled Trial.
    Ghaleiha A; Alikhani R; Kazemi MR; Mohammadi MR; Mohammadinejad P; Zeinoddini A; Hamedi M; Shahriari M; Keshavarzi Z; Akhondzadeh S
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):784-791. PubMed ID: 27128958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baclofen as an adjuvant therapy for autism: a randomized, double-blind, placebo-controlled trial.
    Mahdavinasab SM; Saghazadeh A; Motamed-Gorji N; Vaseghi S; Mohammadi MR; Alichani R; Akhondzadeh S
    Eur Child Adolesc Psychiatry; 2019 Dec; 28(12):1619-1628. PubMed ID: 30980177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prednisolone as Adjunctive Treatment to Risperidone in Children With Regressive Type of Autism Spectrum Disorder: A Randomized, Placebo-Controlled Trial.
    Malek M; Ashraf-Ganjouei A; Moradi K; Bagheri S; Mohammadi MR; Akhondzadeh S
    Clin Neuropharmacol; 2020; 43(2):39-45. PubMed ID: 32168067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of oral folinic acid supplementation in children with autism spectrum disorder: a randomized double-blind, placebo-controlled trial.
    Panda PK; Sharawat IK; Saha S; Gupta D; Palayullakandi A; Meena K
    Eur J Pediatr; 2024 Nov; 183(11):4827-4835. PubMed ID: 39243316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Adding l -Carnitine to Risperidone on Behavioral, Cognitive, Social, and Physical Symptoms in Children and Adolescents With Autism: A Randomized Double-Blinded Placebo-Controlled Clinical Trial.
    Shakibaei F; Jelvani D
    Clin Neuropharmacol; 2023 Mar-Apr 01; 46(2):55-59. PubMed ID: 36735565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism.
    Ghaleiha A; Rasa SM; Nikoo M; Farokhnia M; Mohammadi MR; Akhondzadeh S
    Psychiatry Res; 2015 Sep; 229(1-2):181-7. PubMed ID: 26208985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin as an Adjunctive Therapy to Risperidone in Treatment of Autism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Moazen-Zadeh E; Shirzad F; Karkhaneh-Yousefi MA; Khezri R; Mohammadi MR; Akhondzadeh S
    J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):82-89. PubMed ID: 28719227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism.
    Akhondzadeh S; Fallah J; Mohammadi MR; Imani R; Mohammadi M; Salehi B; Ghanizadeh A; Raznahan M; Mohebbi-Rasa S; Rezazadeh SA; Forghani S
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):32-6. PubMed ID: 19772883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. l -carnitine adjunct to risperidone for treatment of autism spectrum disorder-associated behaviors: a randomized, double-blind clinical trial.
    Nasiri M; Parmoon Z; Farahmand Y; Moradi A; Farahmand K; Moradi K; Basti FA; Mohammadi MR; Akhondzadeh S
    Int Clin Psychopharmacol; 2024 Jul; 39(4):232-239. PubMed ID: 37551601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial.
    Frye RE; Slattery J; Delhey L; Furgerson B; Strickland T; Tippett M; Sailey A; Wynne R; Rose S; Melnyk S; Jill James S; Sequeira JM; Quadros EV
    Mol Psychiatry; 2018 Feb; 23(2):247-256. PubMed ID: 27752075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trial.
    Khalaj M; Saghazadeh A; Shirazi E; Shalbafan MR; Alavi K; Shooshtari MH; Laksari FY; Hosseini M; Mohammadi MR; Akhondzadeh S
    J Psychiatr Res; 2018 Aug; 103():104-111. PubMed ID: 29807317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial.
    Ghaleiha A; Ghyasvand M; Mohammadi MR; Farokhnia M; Yadegari N; Tabrizi M; Hajiaghaee R; Yekehtaz H; Akhondzadeh S
    J Psychopharmacol; 2014 Jul; 28(7):677-85. PubMed ID: 24132248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.